The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma

Surgery

Volumn 144, Issue 6, 2008, Pages 1070-1078

  Zaydfudim, Victor ^a   Feurer, Irene D ^a   Griffin, Marie R ^a   Phay, John E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLICULAR CARCINOMA; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID NEOPLASMS; UNITED STATES;

EID: 56449110873     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.08.034     Document Type: Article

References (18)

1. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 (2006) 2164-2167
2. Solorzano C.C., Carneiro D.M., Ramirez M., Lee T.M., and Irvin III G.L. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 70 (2004) 576-580
3. Senchenkov A., and Staren E.D. Ultrasound in head and neck surgery: thyroid, parathyroid, and cervical lymph nodes. Surg Clin North Am 84 (2004) 973-1000
4. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., and Grant C.S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 (1993) 1050-1057
5. Shaha A.R., Shah J.P., and Loree T.R. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3 (1996) 534-538
6. McHenry C.R., Rosen I.B., and Walfish P.G. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162 (1991) 353-356
7. Leboulleux S., Rubino C., Baudin E., et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90 (2005) 5723-5729
8. Bhattacharyya N. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg 128 (2003) 115-123
9. Podnos Y.D., Smith D., Wagman L.D., and Ellenhorn J.D. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71 (2005) 731-734
10. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
11. In: Greene F.L.P., Fleming D.L., Fritz I.D., Balch A., Haller C.M., and Morrow M. (Eds). Thyroid. In: AJCC cancer staging manual. 6th ed. (2002), Springer, New York
12. National Cancer Institute. Surveillance, epidemiology and end results (SEER) program: Public use data (1973-2004). Available from: http://seer.cancer.gov/data/. Accessed July 2007.
13. Cady B., Sedgwick C.E., Meissner W.A., Bookwalter J.R., Romagosa V., and Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184 (1976) 541-553
14. Sosa J.A., and Udelsman R. Papillary thyroid cancer. Surg Oncol Clin North Am 15 (2006) 585-601
15. Phitayakorn R., and McHenry C.R. Follicular and Hurthle cell carcinoma of the thyroid gland. Surg Oncol Clin North Am 15 (2006) 603-623
16. Dean D.S., and Hay I.D. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 7 (2000) 229-239
17. Mitchell I., Livingston E.H., Chang A.Y., et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 142 (2007) 823-828
18. Podnos Y.D., Smith D.D., Wagman L.D., and Ellenhorn J.D. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. J Surg Oncol 96 (2007) 3-7